Not applicableUnknownNCT05520931What this trial is testingPain-related Long Covid in Covid-19 SurvivorsWho this might be right forCOVID-19Pain, Chronic Aalborg University 600,000
Testing effectiveness (Phase 2)Ended earlyNCT04414631What this trial is testingConestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19Who this might be right forCoronavirus Infections University Hospital, Basel, Switzerland 80
Not applicableStudy completedNCT06334731What this trial is testingAntimicrobial Resistance During the SARS-CoV-2 (COVID-19) PandemicWho this might be right forCOVID-19 Methodist Health System 400
Not applicableStudy completedNCT04750330What this trial is testingMitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 InfectionWho this might be right forCovid19 Maastricht University 394
Not applicableStudy completedNCT04930965What this trial is testingImpact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to VaccinateWho this might be right forCovid19Vaccine Refusal Tulane University 56
Post-approval studies (Phase 4)Study completedNCT05142319What this trial is testingEfficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]Who this might be right forCOVID-19 Tan Tock Seng Hospital 326
Not applicableStudy completedNCT04400877What this trial is testingPrevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 PandemicWho this might be right forCOVID-19Venous ThromboembolismPulmonary Embolism+2 more University Hospital, Linkoeping 7,795
Large-scale testing (Phase 3)WithdrawnNCT04349228What this trial is testingAssessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health ProfessionalsWho this might be right forCOVID19Sars-CoV2Hydroxychloroquine+2 more Abderrahmane Mami Hospital
Not applicableStudy completedNCT06528145What this trial is testingLong Covid (Individuals with Ongoing COVID-19 Symptoms) Ongoing EffectsWho this might be right forCOVID-19 Infection Ziya Yildiz 70
Early research (Phase 1)Study completedNCT05351437What this trial is testingTo Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.Who this might be right forSARS-CoV-2 Infection Memo Therapeutics AG 32
Not applicableStudy completedNCT06130345What this trial is testingPost-marketing Safety of Elasomeran/Davesomeran and AndusomeranWho this might be right forSARS-CoV-2 ModernaTX, Inc. 15,196,685
Not applicableUnknownNCT06085911What this trial is testingRCT Long COVID-19 RehabilitationWho this might be right forRehabilitationPost-Acute COVID-19 SyndromePost-Infectious Disorders University Hospital of North Norway 60
Large-scale testing (Phase 3)Study completedNCT04546581What this trial is testingInpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)Who this might be right forCOVIDCOVID-19SARS-CoV-2+1 more University of Minnesota 593
Early research (Phase 1)Study completedNCT05181709What this trial is testingA Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.Who this might be right forSARS-CoV-2 Sean Liu 35
Not applicableStudy completedNCT05222139What this trial is testingMonitoring COVID-19 Vaccination Response in Fragile PopulationsWho this might be right forSARS CoV 2 InfectionVaccination; InfectionBreakthrough Infection University of Bologna 8,894
Not applicableStudy completedNCT04606407What this trial is testingInhaled NO for the Treatment of Viral Pneumonia in AdultsWho this might be right forViral PneumoniaNitric OxideRespiratory Disease+4 more Beyond Air Inc. 40
Not applicableActive Not RecruitingNCT07816471What this trial is testingRSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed AdultsWho this might be right forRespiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more Hospital Italiano de Buenos Aires 350
Not applicableStudy completedNCT04364711What this trial is testingEuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19Who this might be right forCOVID-19SARS-CoV 2 UMC Utrecht 300
Large-scale testing (Phase 3)UnknownNCT05124171What this trial is testingImmunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary VaccinationWho this might be right forCOVID-19Vaccine Reaction Assistance Publique - Hôpitaux de Paris 247
Not applicableStudy completedNCT05621239What this trial is testingUnderstand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia PeopleWho this might be right forCOVID-19 Pfizer 260